[Treatment of essential hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy*; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents
Die Behandlung der essentiellen Hypertonie